Lv3
210 积分 2025-03-08 加入
Extending Maintenance Dosing Intervals for Guselkumab in the Treatment of Patients With Psoriasis
21小时前
待确认
综合医院的躯体化症状诊治专家共识
1天前
已完结
躯体症状障碍多学科诊疗专家共识
1天前
已完结
Management of Insomnia
17天前
已完结
Disrupted sleep and risk of depression in later life: A prospective cohort study with extended follow up and a systematic review and meta-analysis
20天前
已完结
A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China
21天前
已关闭
[Chinese guidelines for diagnosis and treatment of vulvovaginal candidiasis (2024 edition)]
22天前
已完结
[Expert consensus on diagnosis, treatment and prevention of allergic diseases (Part Ⅱ)]
27天前
已完结
炎症性肠病内镜分级和评分标准的一致性研究
30天前
已完结
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
1个月前
已完结
皖公网安备34019202002308
